New pill for eczema enters first human tests
Symptom relief
Recruiting now
This early-stage study tests a new oral drug called SYX-5219 in healthy volunteers and people with moderate to severe atopic dermatitis (eczema). The main goal is to check safety and how the drug moves through the body. About 149 participants will take single or multiple doses ov…
Phase: PHASE1 • Sponsor: Sitryx Therapeutics Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC